Page last updated: 2024-10-25

dantrolene and Autosomal Dominant Myotubular Myopathy

dantrolene has been researched along with Autosomal Dominant Myotubular Myopathy in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenberg, H1
Rueffert, H1
van Engelen, BG1
Ter Laak, HJ1

Other Studies

2 other studies available for dantrolene and Autosomal Dominant Myotubular Myopathy

ArticleYear
Clinical utility gene card for: malignant hyperthermia.
    European journal of human genetics : EJHG, 2011, Volume: 19, Issue:6

    Topics: Age Factors; Biopsy; Calcium Channels; Calcium Channels, L-Type; Dantrolene; Diagnosis, Differential

2011
Images in neurology. Tubular aggregates: their continuity with sarcoplasmic reticulum.
    Archives of neurology, 1999, Volume: 56, Issue:11

    Topics: Dantrolene; Disease Progression; Humans; Male; Middle Aged; Muscle Relaxants, Central; Muscle, Skele

1999